VECT(Delisted)
VectivBio HoldingยทNASDAQ
--
--(--)
VECT Profile
Vectivbio Holding Ag
A Switzerland-based clinical-stage biopharma that develops treatments for rare gastrointestinal and metabolic disorders
Aeschenvorstadt 36, 4051 Basel, Switzerland
--
VectivBio Holding AG was founded in Switzerland on May 22, 2019. They are a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing innovative treatments for serious rare diseases. Their goal is to become a leading, patient-centric, fully integrated global rare disease company. Their current product line focuses on rare gastrointestinal diseases or gastrointestinal diseases.
